 | ProQR Therapeutics NV (NASDAQ:PRQR) Sees Large Decline in Short Interest
www.americanbankingnews.com - October 16 at 6:08 PM |
 | ProQR prices stock offering; shares down 12% after hours
seekingalpha.com - October 16 at 12:20 AM |
 | ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares
finance.yahoo.com - October 16 at 12:20 AM |
| ProQR's sepofarsen nabs Rare Pediatric Disease status in U.S. for LCA10
seekingalpha.com - October 15 at 7:19 PM |
| Chardan Capital Reaffirms Buy Rating for ProQR Therapeutics (NASDAQ:PRQR)
www.americanbankingnews.com - October 11 at 10:02 PM |
| ProQR Therapeutics (PRQR) Sepofarsen Phase 1/2 Trial Topline Results - Slideshow
seekingalpha.com - October 11 at 6:44 PM |
| Citigroup Increases ProQR Therapeutics (NASDAQ:PRQR) Price Target to $40.00
www.americanbankingnews.com - October 11 at 2:22 PM |
 | ProQR Therapeutics N.V.: ProQR Announces Positive Top-Line Results from the Phase 1/2 Study of Sepofarsen in LCA10 Patients
www.finanznachrichten.de - October 10 at 7:26 AM |
| ProQR's sepofarsen shows positive action in Phase 1/2 study in LCA10
seekingalpha.com - October 10 at 7:26 AM |
| ProQR Announces Positive Top-Line Results from the Phase 1/2 Study of Sepofarsen in LCA10 Patients
finance.yahoo.com - October 10 at 7:26 AM |
| ProQR Therapeutics NV (NASDAQ:PRQR) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - October 9 at 1:48 AM |
| ProQR to Present Top-Line Results from the Phase 1/2 Study of Sepofarsen in LCA10 Patients ahead of AAO
finance.yahoo.com - October 7 at 9:04 AM |
| ProQR Therapeutics Enters Oversold Territory
finance.yahoo.com - October 1 at 4:54 PM |
| ProQR to Present at Two Investor Conferences in October
finance.yahoo.com - September 30 at 7:44 AM |
| Cantor Fitzgerald Weighs in on ProQR Therapeutics NV's FY2019 Earnings (NASDAQ:PRQR)
www.americanbankingnews.com - September 27 at 6:29 AM |
| Is ProQR Therapeutics (NASDAQ:PRQR) Using Too Much Debt?
finance.yahoo.com - September 24 at 3:49 PM |
| ProQR Therapeutics: An In-Depth Assessment
seekingalpha.com - September 17 at 1:13 AM |
| ProQR's QR-1123 Fast Track'd for vision loss disorder; shares up 2%
seekingalpha.com - September 9 at 2:24 PM |
| ProQR Receives Fast Track Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosa
finance.yahoo.com - September 9 at 2:24 PM |
| Mallinckrodt Enrolls First Patient in Liver Disease Study
finance.yahoo.com - August 13 at 6:17 PM |
| ProQR Announces Clearance of IND to Start Clinical Trial of QR-1123 in Patients with Autosomal Dominant Retinitis Pigmentosa (adRP)
finance.yahoo.com - August 12 at 9:32 AM |
| ProQR (PRQR) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 7 at 5:16 PM |
| ProQR Announces Financial Results for the Second Quarter of 2019
finance.yahoo.com - August 7 at 10:42 AM |
| ProQR Therapeutics N.V.: European Medicines Agency Grants PRIME Access to ProQR's Sepofarsen for Leber's Congenital Amaurosis 10
www.finanznachrichten.de - July 29 at 11:44 PM |
| EMA grants PRIME access to ProQr’s sepofarsen for LCA10
seekingalpha.com - July 29 at 6:44 PM |
| European Medicines Agency Grants PRIME Access to ProQR’s Sepofarsen for Leber’s Congenital Amaurosis 10
finance.yahoo.com - July 29 at 8:27 AM |
| What Did ProQR Therapeutics N.V.'s (NASDAQ:PRQR) CEO Take Home Last Year?
finance.yahoo.com - July 26 at 6:37 PM |
| What Did ProQR Therapeutics N.V.'s (NASDAQ:PRQR) CEO Take Home Last Year?
finance.yahoo.com - July 26 at 6:37 PM |
| ProQR up 13% ahead of QR-421a presentation
seekingalpha.com - July 12 at 5:21 PM |
| ProQR Announces Presentation on QR-421a Program in Ophthalmology at Usher Syndrome Coalition Conference in July
finance.yahoo.com - July 2 at 9:47 AM |
| Here’s What Hedge Funds Think About ProQR Therapeutics NV (PRQR)
finance.yahoo.com - June 30 at 9:33 AM |
| ProQR to Present at the JMP Securities Life Sciences Conference
finance.yahoo.com - June 3 at 9:41 AM |
| Did Business Growth Power ProQR Therapeutics's (NASDAQ:PRQR) Share Price Gain of 153%?
finance.yahoo.com - May 27 at 5:32 PM |
| Did Business Growth Power ProQR Therapeutics's (NASDAQ:PRQR) Share Price Gain of 153%?
finance.yahoo.com - May 27 at 5:32 PM |
| ProQR Therapeutics: Near-Term Readout On The Horizon
seekingalpha.com - May 23 at 9:43 AM |
| ProQR to Present at the RBC Capital Markets Healthcare Conference
finance.yahoo.com - May 15 at 9:47 AM |
| ProQR (PRQR) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 8 at 9:44 AM |
| ProQR to Present at Three Scientific Conferences in April
finance.yahoo.com - May 1 at 6:02 PM |
 | ProQR Announces Annual Meeting of Shareholders
www.globenewswire.com - April 18 at 10:16 AM |
| ProQR Doses First Patient in Phase 2/3 ILLUMINATE Trial of Sepofarsen for LCA10
finance.yahoo.com - April 15 at 10:44 AM |
| ProQR to Present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - April 1 at 10:30 AM |
| ProQR spins out DEB unit
seekingalpha.com - March 26 at 6:06 PM |
| ProQR spins out all Dystrophic Epidermolysis Bullosa activities into newly formed Wings Therapeutics created by EB Research Partnership
finance.yahoo.com - March 26 at 6:06 PM |
| ProQR Therapeutics N.V.: ProQR Doses First Patient in Phase 1/2 STELLAR Trial of QR-421a for Usher Syndrome Type 2
www.finanznachrichten.de - March 11 at 10:42 AM |
| ProQR Doses First Patient in Phase 1/2 STELLAR Trial of QR-421a for Usher Syndrome Type 2
finance.yahoo.com - March 11 at 10:42 AM |
| ProQR Therapeutics: What's Bigger, Its Pipeline Or Its 2019 Outlook?
seekingalpha.com - March 5 at 5:37 PM |
| ProQR to Present at Cowen Health Care Conference
finance.yahoo.com - March 5 at 10:17 AM |
| Medicines Company (MDCO) Q4 Loss Widens, Inclisiran in Focus - Yahoo Finance
finance.yahoo.com - March 2 at 9:30 AM |
| ProQR Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
finance.yahoo.com - February 27 at 9:56 AM |
 | Form SC 13G ProQR Therapeutics NV Filed by: RTW INVESTMENTS, LP - StreetInsider.com
www.streetinsider.com - February 24 at 7:51 PM |
